Prescription Opioid Misuse, Comorbid Substance Use, and Suicidal Behaviors Among US Young Adults: Findings from 2015-2019 National Survey on Drug Use and Health

被引:1
作者
Oh, Seungbin [1 ]
Liu, Cindy [2 ,3 ]
Kitchen, Madison [4 ]
Hahm, Hyeouk [5 ]
机构
[1] Boston Univ Chobanian & Avedisian, Sch Med, Dept Psychiat, Boston, MA USA
[2] Brigham & Womens Hosp, Dept Pediat & Psychiat, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] NYU, Silver Sch Social Work, New York, NY USA
[5] Boston Univ, Sch Social Work, Boston, MA 02215 USA
关键词
Prescription opioid misuse; comorbid substance use; suicidal behaviors; young adults; UNITED-STATES; OVERDOSE DEATHS; IDEATION; PREVALENCE; PREDICTORS; CIRCUIT; COCAINE; ABUSE;
D O I
10.1080/10826084.2024.2422950
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background Few studies to date have examined the number of comorbid substances used alongside Prescription Opioid Misuse (POM) to predict suicidal behaviors among US young adults. ObjectiveThis study investigated the relationship between comorbid substance use with POM and suicidal behaviors among the US young adults. Methods Data were from individuals aged 18-25 (N = 69,204, 51.8% female) in the 2015-2019 National Surveys on Drug Use and Health (NSDUH). The final analytic sample for logistic regression was 36,892 young adults. Results After controlling for key covariates, the combination of POM and three or more illicit drugs were at the greatest odds of suicidal ideation (OR = 2.57, 95% CI = 1.61 - 4.11, p < 0.001) and attempts (OR = 3.57, 95% CI = 1.89 - 6.76, p < 0.001) compared to those without POM or drug use. Conclusions The study provides evidence of a dose-response relationship between the number of illicit drugs uses alongside POM and the suicide risk as a clinically important phenomenon with implication for intervention. Findings highlight that POM, with or without illicit drug use, can serve as a behavioral and clinical indicator for identifying young adults at heightened risk of suicidality. This group warrants prioritized intervention targets to ensure timely access to developmentally appropriate clinical treatment, aiming to mitigate addiction progression and prevent harm and mortality.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 48 条
[1]   Suicidal behavior among substance users: data from the Second Brazilian National Alcohol and Drug Survey (II BNADS) [J].
Abdalla, Renata R. ;
Miguel, Andre C. ;
Brietzke, Elisa ;
Caetano, Raul ;
Laranjeira, Ronaldo ;
Madruga, Clarice S. .
BRAZILIAN JOURNAL OF PSYCHIATRY, 2019, 41 (05) :437-440
[2]   Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspective [J].
Alcaro, Antonio ;
Huber, Robert ;
Panksepp, Jaak .
BRAIN RESEARCH REVIEWS, 2007, 56 (02) :283-321
[3]  
[Anonymous], 2023, Drug Overdose Death Rates
[4]  
[Anonymous], 2016, Prescription drug use and misuse in the United States: Results from the 2015 National Survey on Drug Use and Health
[5]  
[Anonymous], 2014, Harmful interactions
[6]  
[Anonymous], 2023, Suicide prevention
[7]  
[Anonymous], 2019, 2019 National Survey of Drug Use and Health (NSDUH) Releases | CBHSQ Data
[8]  
[Anonymous], 2021, SAMHSAs Commitment to Suicide Prevention
[9]  
Arnett JJ, 2000, AM PSYCHOL, V55, P469
[10]   Frequency of prescription opioid misuse and suicidal ideation, planning, and attempts [J].
Ashrafioun, Lisham ;
Bishop, Todd M. ;
Conner, Kenneth R. ;
Pigeon, Wilfred R. .
JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 92 :1-7